Recombinant mid gut antigen (Bm95) as a vaccine against Indian Rhiphicephalus haemaphysaloides in Bos indicus cattle.
|
| Abstract |
In the present study, we report for the first time the efficacy of recombinant Bm95 mid gut antigen isolated from an Argentinean strain of Rhipicephalus microplus strain A in controlling the tick infestations in India. The synthetic gene for Bm95 optimized for expression in yeast was obtained and used to generate yeast transformants expressing Bm95 which was purified to apparent homogeneity. Liquid chromatography-mass spectrometry analysis of the purified protein confirmed its identity as Bm95. Vaccine was prepared by blending various concentrations of purified Bm95 with aluminium hydroxide as an adjuvant. Immunogenicity studies of the vaccine in rabbits and cattle indicated that the vaccine was highly immunogenic. The efficacy studies of the vaccine was done in cattle. Naïve Bos indicus cattle were vaccinated with the recombinant vaccine and were challenged with the larval, nymphal and adult forms of Rhiphicephalus haemaphysaloides. The vaccine protected the animals from larval, nymph and adult tick challenges with an efficacy of 98.7%, 84.6% and 78.9% respectively. The results obtained from the above studies clearly demonstrated the advantage and possibilities of the use of Bm95 in controlling R. haemaphysaloides infestations in the field.
|
|---|---|
| Authors | Parthasarathy Sugumar, Dev Chandran, Gudavalli Sudha Rani, Pallichera Vijayan Shahana, Dasarath Keshavrao Maske, Pundi Narasimhan Rangarajan, Lakshmi Narasu Mangamoori, Villuppanoor Alwar Srinivasan |
| Journal | Research in veterinary science (Res Vet Sci) Vol. 90 Issue 2 Pg. 262-8 (Apr 2011) ISSN: 1532-2661 [Electronic] England |
| PMID | 20580387 (Publication Type: Journal Article) |
| Copyright | Copyright © 2010 Elsevier Ltd. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!